Product infomation

CynosBio Announces Last Patient Implanted in Japan Phase 3 IK-01 Trial for Knee Osteoarthritis

Product infomation

CynosBio Selected for AMED Support to Advance Japan-Approved SAKRACY® Toward an International Phase 3 Trial

Announcements for products

Announcement of the start of Phase III clinical trials of IK-01 for the treatment of osteoarthritis of the knee